Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SSRIs and fracture risk

A recent article discussed the link found between proton pump inhibitors and increased hip fracture risk, now a paper in the Archives of Internal Medicine has identified an association between clinical fragility fracture and daily selective serotonin reuptake inhibitor (SSRI) use.

The study collected data for 5,008 patients aged 50 years and older over a 5-year period. Clinical fragility fractures were identified if radiographically confirmed. Daily SSRI use was report in 137 patients and after adjusting for several covariates the hazard rate was calculated to be 2.1 [95% CI 1.3-3.4]. There were also associations with falls and lower bone mineral density at the hip.

There are potential confounders in the study. Patients with depression may be less likely to eat a well balanced diet. These patients may also have depression as the consequence of chronic co-morbidity.

Action: Clinicians should be aware of the possible increased fracture risk with SSRIs. Depression should still be appropriately treated and fragility fracture risk managed with dietary advice and treatment where appropriate.

Share 'SSRIs and fracture risk' on Email Share 'SSRIs and fracture risk' on Delicious Share 'SSRIs and fracture risk' on Digg Share 'SSRIs and fracture risk' on Facebook Share 'SSRIs and fracture risk' on Google+ Share 'SSRIs and fracture risk' on reddit Share 'SSRIs and fracture risk' on StumbleUpon Share 'SSRIs and fracture risk' on Twitter

atomic-wealth

No Comments to “SSRIs and fracture risk”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,601 spam comments.

atomic-wealth
fond-illness
summer